Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.46 EUR
Change Today -0.05 / -1.42%
Volume 0.0
MED On Other Exchanges
Symbol
Exchange
Xetra
As of 3:35 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

mediclin ag (MED) Snapshot

Open
€3.46
Previous Close
€3.51
Day High
€3.57
Day Low
€3.45
52 Week High
11/10/14 - €4.00
52 Week Low
10/16/14 - €3.30
Market Cap
164.4M
Average Volume 10 Days
1.6K
EPS TTM
€0.25
Shares Outstanding
47.5M
EX-Date
05/28/12
P/E TM
13.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICLIN AG (MED)

Related News

No related news articles were found.

mediclin ag (MED) Related Businessweek News

No Related Businessweek News Found

mediclin ag (MED) Details

MEDICLIN Aktiengesellschaft operates hospitals and provides services in the areas of neurosciences, psychological sciences, and orthopedics in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. The Post-Acute segment offers services in the fields of subsequent nursing and curative treatments. This segment’s subsequent nursing treatment includes various medical measures required to facilitate the healing process and return the patient to a functioning state after acute care treatment; and curative treatment comprises prophylactic measures against the occurrence or reoccurrence of illnesses. The Acute segment encompasses medical offerings focusing on neurology and neurological early rehabilitation, as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. This segment also offers services in the areas of cardiology, oncology, and ENT; and provides acute outpatient services. The Other Activities segment offers full-time and short-term nursing care; and outpatient nursing care in the nursing care facilities. The company operates 34 clinics, 7 nursing care facilities, and 8 medical care centers with a total capacity of approximately 8,000 beds in 11 German federal states. MEDICLIN Aktiengesellschaft is headquartered in Offenburg, Germany.

6,492 Employees
Last Reported Date: 07/31/15

mediclin ag (MED) Top Compensated Officers

Chairman of Management Board
Total Annual Compensation: €800.0K
Chief Financial Officer and Member of the Man...
Total Annual Compensation: €415.5K
Compensation as of Fiscal Year 2014.

mediclin ag (MED) Key Developments

Mediclin Aktiengesellschaft Reports Group Earnings Results for the First Half Ended June 30, 2015

MediClin Aktiengesellschaft reported group earnings results for the first half ended June 30, 2015. For the period, the company reported sales of EUR 274.2 million against EUR 266.7 million a year ago, thus being EUR 7.5 million or 2.8 % above the value of the first half-year of 2014. EBIT improved compared to the first half-year of 2014 by EUR 3.5 million from EUR 3.1 million to EUR 6.6 million and the result attributable to the company’s shareholders by EUR 3.3 million from EUR 1.0 million to EUR 4.3 million.

Mediclin AG Reports Earnings Results for the First Quarter of 2015

Mediclin AG reported earnings results for the first quarter of 2015. For the quarter, the company reported achieved group sales of EUR 136.6 million compared with EUR 132.4 million for the same period last year thus being EUR 4.2 million or 3.1% above the value of the first quarter 2014. The result after tax attributable to shareholders of MediClin AG of the first quarter 2015 improved by EUR 2.5 million from EUR 1.7 million to EUR 0.8 million.

MEDICLIN Aktiengesellschaft Announces Preliminary Group Earnings Results for the Year 2014

MEDICLIN Aktiengesellschaft announced preliminary group earnings results for the year 2014. The company achieved group sales of EUR 538.0 million in the 2014. The sales plus was EUR 23.1 million or 4.5% against previous year. The large share of sales growth - about eighty percent - accounted for the post-acute segment, which had not to face the usual seasonal slowdown of occupancy in the first and fourth quarter 2014. The preliminary group operating result increased from EUR 2.2 million to EUR 15.6 million. Earnings attributable to shareholders was EUR 8.5 million compared with loss attributable to shareholders of EUR 2.6 million a year ago. Earnings per share account to EUR 0.18 compared with loss per share of EUR 0.06 a year ago. The company invested EUR 21.0 million in capital expenditure in the 2014 fiscal year compared to EUR 18.6 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MED:GR €3.46 EUR -0.05

MED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MED.
View Industry Companies
 

Industry Analysis

MED

Industry Average

Valuation MED Industry Range
Price/Earnings 14.2x
Price/Sales 0.3x
Price/Book 1.1x
Price/Cash Flow 5.6x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICLIN AG, please visit www.mediclin.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.